CreatorsPublishersAdvertisers
View more in
Cancer

Dr. Manasanch on Key Takeaways From CASSIOPEIA in Multiple Myeloma

onclive.com
 2021-08-03

Elisabet E. Manasanch, MD, discusses key lessons learned from the phase 3 CASSIOPEIA trial in patients with newly diagnosed multiple myeloma. Elisabet E. Manasanch, MD, associate professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses key lessons learned from the phase 3 CASSIOPEIA trial (NCT02541383) in patients with newly diagnosed multiple myeloma.

www.onclive.com

Comments / 0

Comments / 0